Skip to main content

Find Clinical Trials

Home
Conditions
B7-H3-positive Relapsed/ Refractory Neuroblastoma

Clinical trial condition

B7-H3-positive Relapsed/ Refractory Neuroblastoma

Explore clinical trials studying B7-H3-positive Relapsed/ Refractory Neuroblastoma. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study

Refine in advanced search Browse all conditions

B7-H3-positive Relapsed/ Refractory Neuroblastoma trial results

Recruiting

TAA06 Injection in the Treatment of Patients With B7-H3-positive Relapsed/ Refractory Neuroblastoma

NCT05562024

Conditions: B7-H3-positive Relapsed/ Refractory Neuroblastoma
Locations: Shandong Cancer Hospital and Institute Jinan, Shandong, China

Tianjin Medical University Cancer Institute and Hospital Tianjin, Tianjin Municipality, China

View Trial Details